# A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation II

> **NCT05333107** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 152 (actual)

## Conditions studied

- Healthy Volunteers; High Cholesterol

## Interventions

- **DRUG:** NNC0385-0434 G
- **DRUG:** NNC0385-0434 F
- **DRUG:** NNC0385-0434 B

## Key facts

- **NCT ID:** NCT05333107
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-12
- **Primary completion:** 2022-07-22
- **Final completion:** 2022-09-23
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2024-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05333107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05333107, "A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation II". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05333107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*